Jm. Sancho et al., PROPERTIES OF THE PURIFIED HYPOTHALAMIC-PITUITARY NA K-ATPASE INHIBITOR/, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000032-190000034
Previously we described the isolation and final purification of an end
ogenous sodium-pump inhibitor from the CNS, mainly from bovine hypotha
lamus and pituitary. The purification protocol consisted of lipophilic
chromatography, followed by lipid extraction, and semi-preparative an
d analytical reverse-phase high-pressure liquid chromatography. The bi
oassays used were in vitro Na+/K+-ATPase inhibition, and H-3-ouabain d
isplacement from its specific binding site in the enzyme structure, as
well as inhibition of Rb-86 uptake from human red blood cells. We hav
e obtained, from both tissues, a low-molecular-weight, nonpeptidic, no
nlipidic substance that elutes as a single peak highly pure according
to criteria of coincidence of its spectra properties. When rechromatog
raphed in two different chromatographic systems, the same homogeneous
peak is obtained suggesting complete purity. This pure substance can b
e isolated from other bovine tissues as well as from human plasma and
human placenta. It shows a very distinctive fluorescence spectrum and
it behaves as a potent inhibitor of the Ca2+ pump of synaptosomal plas
ma membrane.